v3.25.2
Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Preferred stock, par value (in Dollars per share) $ 0.0001 [1] $ 0.0001
Preferred stock, shares authorized (in Shares) 1,000,000 [1] 1,000,000
Preferred stock, shares issued (in Shares) 0 [1] 0
Preferred stock, shares outstanding (in Shares) 0 [1] 0
Common stock, par value (in Dollars per share) $ 0.0001 [1] $ 0.0001
Common stock, shares authorized (in Shares) 999,000,000 [1] 999,000,000
Common stock, shares outstanding (in Shares) 277,310,193 [1] 220,657,014
Common stock, shares issued (in Shares) 277,310,193 [1] 220,657,014
Treasury stock, at cost (in Shares) 424,483 [1] 128,138
Total Assets (in Dollars) [2] $ 3,247,255,700 [1] $ 938,287,500
Cash and Cash Equivalents (in Dollars) 1,343,901,700 [1],[2] 170,236,100
Total liabilities (in Dollars) [2] 965,127,400 [1] 24,697,400
VIEs [Member]    
Total Assets (in Dollars) 2,303,800 0
Cash and Cash Equivalents (in Dollars) 2,303,800  
Total liabilities (in Dollars) $ 0 $ 0
[1] Under certain provisions of Accounting Standards Codification (“ASC”) 810, Consolidations, (“ASC 810”) we are required to separately disclose on our condensed consolidated balance sheets the assets of the consolidated variable interest entity (“VIE”) that are owned by the consolidated VIE and liabilities of the consolidated VIE as to which there is no recourse against us.
[2] As of June 30, 2025, the total assets include $2,303.8 related to the consolidated VIE of which $2,303.8 is included in cash and cash equivalents.  Total liabilities included related to the consolidated VIE were $0.0.  As of December 31, 2024, we did not have a variable interest in the VIE, as a result no assets and liabilities of the VIE are included in our condensed consolidated balance sheet. There is no recourse against us for the liabilities of the consolidated VIE.